Weil Helps Sanofi Buy Rare Diseases Co. For Up To $2.2B
By Najiyya Budaly · January 23, 2024, 11:27 AM GMT
French healthcare giant Sanofi SA said Tuesday that it will buy a U.S. company that creates therapies for so-called orphan diseases for approximately $2.2 billion in cash as it seeks to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login